OBIO: orchestrabiomed.com Growth-Adjusted Market Cap to Net Income
The P/E ratio justification indicator exhibits volatile dynamics, where 0.00 shapes the current metric. The price decline is linked to the environmental optimization of cardio-device packaging. However, geopolitical risks in electronics supplies and software certification complexities create pressure, which is offset by the flawless image of Orchestra BioMed (OBIO) and physicians' trust in their innovative systems.
Orchestra BioMed, Inc. (OBIO) - metric breakdowns and financial figures
- current price and projected stock value:
- market capitalization information:
- company book value details:
- business debt structure and liquidity details:
Debt to Equity Ratio Orchestra BioMed|OBIO - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Orchestra BioMed Inc.|OBIO - Company Debts|Debt to Book Value Orchestra BioMed|OBIO - Company Long-Term Debts|Short-Term Debt Orchestra BioMed|Immediate Liquidity Ratio orchestrabiomed.com
- earnings and valuation multiples indicators:
OBIO - Net Profit|Company Profit Forecast Orchestra BioMed|OBIO - P/E Multiple|Projected Price to Earnings orchestrabiomed.com|OBIO - PEG Multiple|EV/EBITDA Multiple Orchestra BioMed|OBIO - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Orchestra BioMed|OBIO - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months orchestrabiomed.com|OBIO - Earnings growth in current year|Expected net earnings per share growth next year Orchestra BioMed
Fundamental company analysis:OBIO (orchestrabiomed.com)
The PEG ratio determines investment attractiveness by comparing the current earnings multiple to the growth rate, where a value below one indicates that the asset is undervalued. By analyzing the peg_co ratio, an investor finds mathematical confirmation of the stability of Orchestra BioMed (OBIO), whose ambitious growth rates are supported by high confidence from cardiologists and strategic alliances with medical technology leaders.
Competing companies
Price/Earnings to Growth Ratio BSX (Boston Scientific Corp)|PEG Multiple EW (Edwards Lifesciences Corp)|Growth-Adjusted Market Cap to Net Income ResMed Corporation (RMD)|PODD: Price/Earnings to Growth Multiple|Market Cap to Earnings and Growth Ratio ZBH|COO: PEG Multiple|Price to Earnings Adjusted for Growth Rate Invisalign (ALGN)|GMED (Globus Medical Corp) - PEG Multiple|Growth-Adjusted P/E Ratio TMDX (transmedics.com)|Price/Earnings to Growth Multiple ATEC (Alphatec Holdings, Inc.)|AORT (artivion.com) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Enovis ENOV|IART - Price/Earnings to Growth Multiple|Motiva - PEG Multiple|Price to Earnings Adjusted for Growth Rate iLet Bionic Pancreas|IRMD: PEG Multiple|Growth-Adjusted P/E Ratio EMBC|TNDM (Tandem Diabetes Care, Inc.) - PEG Multiple|AxoGen Inc (AXGN) - Growth-Adjusted Market Cap to Net Income|PEG Multiple SIBN|Price/Earnings to Growth Multiple Orthofix Corp OFIX|PEG Multiple BVS (Bioventus Inc.)|PEG Multiple OrthoPediatrics Corp KIDS|TMCI - Price/Earnings to Growth Ratio|SRTA: Price/Earnings to Growth Ratio|CARL (Carlsmed Corp) - Price/Earnings to Growth Multiple|RxSight Ophthalmic - Growth-Adjusted Payback Ratio|CLPT (ClearPoint Neuro Inc.) - PEG Multiple|Price to Earnings Adjusted for Growth Rate stereotaxis.com STXS|Price/Earnings to Growth Ratio Neuronetics (STIM)|Sight Sciences Inc. (SGHT) - Price to Net Income Growth Ratio|Anika Therapeutics, Inc. - Price/Earnings to Growth Multiple|PEG Multiple InspireMD Inc. NSPR|Jin Medical International Ltd - PEG Multiple|Growth-Adjusted Market Cap to Net Income Vivani Medical, Inc. VANI|xtantmedical.com (XTNT) - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio NMTC (NeuroOne)|Price/Earnings to Growth Ratio Modular Medical Inc|Price/Earnings to Growth Multiple Myomo Inc (MYO)|PEG Multiple COCH|VVOS - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio enVVeno Medical Corp. NVNO|SINT: Growth-Adjusted P/E Ratio|TNON: Price/Earnings to Growth Multiple|Lifeward Ltd. - Company Value to Earnings Growth Ratio|autonomix.com (AMIX) - Price/Earnings to Growth Ratio|Price to Earnings Adjusted for Growth Rate invobioscience.com (IVF)|Price/Earnings to Growth Ratio Bone Biologics Corp|AXNX: Growth-Adjusted Payback Ratio|PEG Multiple BIOL|Price/Earnings to Growth Multiple dynatronics.com DYNT|PEG Multiple FNA (Paragon 28)|Growth-Adjusted Payback Ratio INVO
